Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2005
03/30/2005CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1194975C Helerocyclic substituted benzoxazine cyclic compound having biological activity
03/29/2005US6872833 Alzheimer's disease; Parkinson's disease; antidepressants
03/29/2005US6872740 4-(heteroarylethyl)-4,5-dihydro-1,3-thiazol-2-ylamine or salt, useful for treating an illness, which involves an abnormal production of nitric oxide (NO) by induction of an inducible NO-synthase
03/29/2005US6872737 Drugs such as 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5 -dione inhibitors of glycogen synthase kinase-3 (GSK-3), for prophylaxis of neurodegenerative disorders, cancer, hyperplasia, psoriasis, arteriosclerosis or restinosis
03/29/2005US6872735 LFA-1 antagonist compounds
03/29/2005US6872732 Heterocyclic derivatives and medicinal use thereof
03/29/2005US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/29/2005US6872724 Active polymorphs of 4-(2-(5- cyano-thiazol-2-ylamino) pyridin-4-ylmethyl)-piperazine-1-active polymorphs of 4-(2 5-cyano-thiazol-2-ylamino)-pyridin-4-ylmethyl)piperazine-1-carbo xylic acid methylamide which inhibit, regulate and/or modulate
03/29/2005CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
03/24/2005WO2005026263A1 Azo metal chelate coloring matter and optical recording medium
03/24/2005WO2005026177A1 Substituted piperazines of azepines, oxazepines, and thiazepines
03/24/2005WO2005026165A1 Quinolone antibacterial agents
03/24/2005WO2005026163A1 Dioxolane derivatives as cell adhesion inhibitors
03/24/2005WO2005026162A1 Gyrase inhibitors
03/24/2005WO2005026158A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
03/24/2005WO2005026156A1 Quinazoline derivatives
03/24/2005WO2005026155A1 Benzimidazole acetonitriles
03/24/2005WO2005026154A1 Quinolone antibacterial agents
03/24/2005WO2005026152A1 Quinazoline derivatives as antitumor agents
03/24/2005WO2005026151A1 Quinazoline derivatives as tyrosine kinase inhibitors
03/24/2005WO2005026149A1 Pyrrol derivatives with antibacterial activity
03/24/2005WO2005026139A1 Nematicidal difluoroalkenes
03/24/2005WO2005026137A2 Modulators of atp-binding cassette transporters
03/24/2005WO2005026136A2 2, 2'-azino-bis-thiazolines and uses thereof as air- and water- stable radical precursors
03/24/2005WO2005026131A1 Transition state structure and inhibitors of thymidine phosphorylases
03/24/2005WO2005026129A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
03/24/2005WO2005026127A1 Plasminogen activator inhibitor-1 inhibitor
03/24/2005WO2005026123A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use
03/24/2005WO2005026113A1 1, 3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases
03/24/2005WO2005026111A2 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
03/24/2005WO2005025681A2 A system for and a method of manufacturing personal golf putters
03/24/2005WO2005025572A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
03/24/2005WO2005016325A3 CRISTALLINE ZIPRASIDONE HCl AND PROCESSES FOR PREPARATION THEREOF
03/24/2005WO2005009967A3 Quinolinone derivatives as inhibitors of c-fms kinase
03/24/2005WO2004096135A3 Inhibitors of akt activity
03/24/2005WO2004087050A3 Mitotic kinesin inhibitors
03/24/2005WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors
03/24/2005WO2004064730A3 Compounds, compositions and methods
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005WO2004039795A3 Amide compounds for the treatment of hyperlipidemia
03/24/2005US20050065353 Mitosis agents; antitumor agents; anticancer agents
03/24/2005US20050065197 Thiazole derivatives with fungicidal activity
03/24/2005US20050065196 Azole compound and medicinal use thereof
03/24/2005US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
03/24/2005US20050065189 Thiazole derivatives as cannabinoid receptor modulators
03/24/2005US20050065188 Aryl or heteroaryl amide compounds
03/24/2005US20050065166 Herbicides; plant safening agents
03/24/2005US20050065163 Platelet adenosine diphosphate receptor antagonists
03/24/2005US20050065150 Lipoxygenase moderators; autoimmune disease; neurodegenerative disease; respiratory system disorders; cardiovascular disorders; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis
03/24/2005US20050065149 Neurodegenerative disorders; antiinflammatory agents; strokes; antiischemic agents; neuropathic pain; brain disorders; antiepileptic agents; Parkinson's disease ; amyotropic lateral sclerosis; Alzheimer's disease; antidiabetic agents
03/24/2005US20050065148 Dipeptidyl peptidase inhibitors
03/24/2005US20050065140 Antidepressant; side effect reduction
03/24/2005US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents
03/24/2005US20050065099 Treatment of mitochondrial diseases
03/24/2005US20050065095 Antibacterial agents
03/24/2005US20050065066 Stabilised insulin compositions
03/24/2005CA2541100A1 Quinazoline derivatives
03/24/2005CA2539024A1 Quinazoline derivatives as antitumor agents
03/24/2005CA2539022A1 Quinazoline derivatives as tyrosine kinase inhibitors
03/24/2005CA2538909A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
03/24/2005CA2538552A1 Pyrrol derivatives with antibacterial activity
03/24/2005CA2538420A1 Quinolone antibacterial agents
03/24/2005CA2538339A1 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
03/24/2005CA2537860A1 Gyrase inhibitors
03/24/2005CA2537841A1 Modulators of atp-binding cassette transporters
03/24/2005CA2537660A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
03/24/2005CA2536633A1 Fused ring heterocycles as potassium channel modulators
03/24/2005CA2536107A1 Substituted piperazines of azepines, oxazepines, and thiazepines
03/24/2005CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
03/23/2005EP1515750A1 Combinations comprising epothilones and pharmaceutical uses thereof
03/23/2005EP1515724A1 Mitotic kinesin inhibitors
03/23/2005EP1515722A2 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1515721A1 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1347969B1 5- (pyrazol-4-yl)carbonyl]benzazolone as herbicide
03/23/2005EP1280795B1 N-substituted carbamoyloxyalkyl-azolium derivatives
03/23/2005EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
03/23/2005EP1028949B1 Carbamoylphenylsulfonyl ureas, method for their production and their application as herbicides and plant growth regulators
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599731A Benzothiazepine derivatives
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599728A 1, 2, 4-triazole derivatives containing a sulphamate group as aromatase inhibitors
03/23/2005CN1599725A Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1598699A Linked dihydrazone-based charge transport compounds
03/23/2005CN1598698A Organophotoreceptor with charge transport compound with an azine group
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6870058 Polyhydroxy, dienyl lactones and intermediates
03/22/2005US6870056 Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
03/22/2005US6869974 Pharmaceutical compounds
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents
03/22/2005US6869943 Sorbitol dehydrogenase inhibitors